Undervalued Large-Cap Healthcare Stocks on TSE June 2025

June 11, 2025

Healthcare Sector

The healthcare sector includes companies in biotechnology, pharmaceuticals, hospitals, home and long-term care. It also includes related medical equipment manufacturers and suppliers.

Toronto Stock Exchange

The Toronto Stock Exchange (TSE) is a stock exchange located in Toronto, Ontario, Canada. It is the 10th largest exchange in the world and the third largest in North America based on market capitalization.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Healthcare stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
BHC Bausch Health Companies 6.22 12.44 99.97 374190 2299 0.00 0.0
BLCO Bausch & Lomb 15.55 16.91 8.77 4638 5486 0.00 0.0
All data provided as at market close May 29, 2025.

Company Details

Bausch Health Companies

BHC:TSX

Close Price

6.22

Our Valuation

12.44

% Difference

99.97

Market Cap ($M)

2299

P/E Ratio

0.0

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Access the stockcalc valuation


Bausch & Lomb

BLCO:TSX

Close Price

15.55

Our Valuation

16.91

% Difference

8.77

Market Cap ($M)

5486

P/E Ratio

0.0

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify.

Access the stockcalc valuation


Bausch Health Companies and Bausch & Lomb are the most undervalued Large-Cap Healthcare stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-tse-june-2025
Bausch Health Companies $BHC and Bausch & Lomb $BLCO are the most undervalued Healthcare stocks on the #TSE. See the full list: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-tse-june-2025
Bausch Health Companies and Bausch & Lomb are the most undervalued Large-Cap Healthcare stocks on the TSE. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-tse-june-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.